Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

Pazopanib

800 mg QD p.o.

Trial Locations (1)

Unviersity Hospital of Münster (UKM), Münster